Prescription Required
Consuming alcohol with CA 007 125 mg/500 mg Injection does not cause any harmful side effects.
CA 007 125 mg/500 mg Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
CA 007 125 mg/500 mg Injection is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.<BR>Avoid prolonged use of CA 007 125 mg/500 mg Injection, since it may have possible effects such as rash and diarrhea.
CA 007 125 mg/500 mg Injection may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
CA 007 125 mg/500 mg Injection should be used with caution in patients with kidney disease. Dose adjustment of CA 007 125 mg/500 mg Injection may be needed. Please consult your doctor.
CA 007 125 mg/500 mg Injection is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of CA 007 125 mg/500 mg Injection may not be needed in these patients. Please consult your doctor.
CA 007 125 mg/500 mg Injection is a combination of two medicines: Amikacin and Cefepime. Amikacin is an antibiotic which stops bacterial growth by preventing the synthesis of essential proteins required by bacteria to carry out vital functions. Cefepime is also an antibiotic which works by preventing the formation of the bacterial protective covering which is essential for the survival of bacteria in the human body. Together, they eradicate your infection effectively.
Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA